International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches

Author(s): Allen Loyd V Jr

Issue: May/Jun 2015 - Volume 19, Number 3
View All Articles in Issue

Page(s): 244

Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, methylphenidate hydrochloride, central nervous system stimulant, attention deficit disorder, narcolepsy

Related Categories: FORMULATIONS, MENTAL HEALTH, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Allen Loyd V Jr	May/Jun 2015 Pg. 244
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Methylphenidate Hydrochloride 10-mg Capsules Allen Loyd V Jr	Nov/Dec 2014 Pg. 501
Methylphenidate in the Treatment of Attention Deficit Disorders Tenreiro Kim	Jan/Feb 2001 Pg. 21-22
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Allen Loyd V Jr	Nov/Dec 2014 Pg. 496
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Methylphenidate 1-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 249
Attention Deficit Hyperactivity Disorder Allen Loyd V Jr	Mar/Apr 1997 Pg. 87-89
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 133
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Allen Loyd V Jr	Mar/Apr 2015 Pg. 148
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Allen Loyd V Jr	May/Jun 2008 Pg. 267
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 418
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Allen Loyd V Jr	May/Jun 2009 Pg. 246
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 457
Sotalol Hydrochloride 5-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 144
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
Labetalol Hydrochloride 5-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2012 Pg. 160
Diltiazem Hydrochloride 5-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 241
Return to Top